Detalhe da pesquisa
1.
Real-world effectiveness of sotrovimab and remdesivir for early treatment of high-risk hospitalized COVID-19 patients: A propensity score adjusted retrospective cohort study.
J Med Virol
; 95(2): e28460, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602046
2.
Real-World Use of Sotrovimab for Pre-Emptive Treatment in High-Risk Hospitalized COVID-19 Patients: An Observational Cross-Sectional Study.
Antibiotics (Basel)
; 11(3)2022 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35326808